This cluster is too small to warrant a trade signal. Monitor for any upcoming material filings (earnings, pipeline updates, M&A) that could explain the sales, but the dollar amounts are routine portfolio management. No action needed.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 1 $33.26entry
- T+1 · 7mo ago +2.65%α +2.99% · $34.14
- T+5 · 6mo ago +6.44%α +4.10% · $35.40
- T+20 · 6mo ago +27.10%α +21.82% · $42.27
- T+60 · 4mo ago +58.55%α +55.99% · $52.73
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Alkermes insiders, the EVP/CLO and EVP R&D/Chief Medical Officer, sold a combined $368K in open-market stock over four days, with the CMO also exercising options. The total sales represent ~0.007% of Alkermes' $5.5B market cap, a trivial amount that carries no material signal.
Key Financial Metrics
Key Facts
- Two insiders sold a combined $368K in open-market shares over 4 trading days
- EVP/CLO David Gaffin sold 2,034 shares at $33.20 for $68K on May 4
- EVP R&D/CMO Craig Hopkinson sold 9,000 shares at $33.40 for $301K on May 1, after exercising options
- Total sales represent ~0.007% of Alkermes' $5.5B market cap, well below the 0.1% materiality threshold
- No insider buying was reported in the cluster window
Financial Impact
Total insider sales of $368K, or 0.007% of market cap, economically trivial
Risk Factors
- Insider selling could accelerate if a negative catalyst emerges, but this cluster alone is not predictive
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALKS-1777941791289 |
Track record
23 reports on ALKS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers